---
schema_version: "secwatch.filing_event.v1"
accession: "0001618835-23-000017"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2023-03-17T23:59:59+00:00"
generated_at: "2026-06-17T23:35:52.584214+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Evofem stockholders approve reverse stock split of 1-for-20 to 1-for-125

## Summary
- Special Meeting held March 15, 2023; 67.96% of eligible shares represented.
- Approval: 132,595,045 for, 23,270,478 against, 1,693,299 abstain.
- Board has discretion to set exact ratio as a whole number within 1:20 to 1:125 range.
- Reverse split must be effected on or before March 15, 2024.
- Company's common stock trades on OTCQB under symbol EVFM.

## SEC filing metadata
- accession: 0001618835-23-000017
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2023-03-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000161883523000017/0001618835-23-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000161883523000017/evfm-20230315.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001618835-23-000017
- JSON: https://secwatch.observer/filing/0001618835-23-000017.json
- Plain text: https://secwatch.observer/filing/0001618835-23-000017.txt

## Key facts
- Shareholder Votes
  Evofem Biosciences, Inc. shareholders approved Approval of an amendment to the Company's Certificate of Incorporation to effectuate a reverse stock split of the outstanding shares of the Company's common stock by a ratio of not less than 1-for-20 and not more than 1-for-125 at any time on or prior to March 15, 2024, with the exact ratio to be se at the 2023-03-15 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-03-15
  source text: Proposal No. 1: The Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to effectuate a reverse stock split of the outstanding shares of the Company’s common stock by a ratio of not less than 1-for-20 and not more than 1-for-125 at any time on or prior to March 15, 2024, with the exact ratio to be set at a whole number within such range by the Company’s board of directors (the “Board”), at the sole discretion of the Board, as follows: Votes For Votes Against Abstentions Broker Non-Votes 132,595,045 23,270,478 1,693,299 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000161883523000017/0001618835-23-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.